Cytokines and chemokines in the immune response to hepatitis C infection

Current Opinion in Infectious Diseases

Volumn 14, Issue 3, 2001, Pages 279-287

  Heydtmann, Mathis ^a   Shields, Philip ^a   McCaughan, Geoffrey ^a   Adams, David ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CYTOKINE; INTERFERON; VIRUS PROTEIN;

CYTOKINE RELEASE; EFFECTOR CELL; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNE RESPONSE; LIVER DISEASE; LIVER FIBROSIS; MORALITY; PERSISTENT VIRUS INFECTION; REVIEW; SURVIVAL; T LYMPHOCYTE; TISSUE INJURY;

EID: 0035016143     PISSN: 09517375     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001432-200106000-00006     Document Type: Review

References (95)

1. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins
2. IL-18 induces the differentiation of Th1 or Th2 cells depending upon cytokine milieu and genetic background
3. IL-18 promotes type 1 cytokine production from NK cells and T cells in human intracellular infection
4. Two roads diverged: Interferon alpha/beta- and interleukin 12-mediated pathways in promoting T cell interferon gamma responses during viral infection
5. Induction of bystander T-cell proliferation by viruses and type-1 Interferon in-vivo
6. Natural killer cells in antiviral defense: Function and regulation by innate cytokines
7. IFN-alpha and IFN-beta: A link between immune memory and chronic inflammation
8. + T-helper and a T-killer cell
9. Cytotoxic T-cell immunity to virus-infected non-haematopoietic cells requires presentation of exogenous antigen
10. Induction of cell death by tumour necrosis factor (TNF) receptor 2, CD40 and CD30: A role for TNF-R1 activation by endogenous membrane-anchored TNF
11. CD40 activation induces apoptosis in cultured human hepatocytes via induction of cell surface FasL expression and amplifies Fas mediated hepatocyte death during allograft rejection
12. Chemokine receptors and their role in inflammation and infectious diseases
13. Chemokines and their receptors in allograft rejection
14. A transmembrane CXC chemokine is a ligand for HIV-coreceptor Bonzo
15. Chemokines and T lymphocytes: More than an attraction
16. Modulation of cytokine function by proteoglycans: Sophisticated models for the regulation of cellular responses to cytokines
17. Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4
18. Cutting edge: Developmental switches in chemokine responses during T cell maturation
19. Chemokines and cell migration in secondary lymphoid organs
20. Dual personality of memory T cells
21. Lack of chemokine receptor CCR1 enhances Th1 responses and glomerular injury during nephrotoxic nephritis
22. Modulation of chemokines by poxvirus infections
23. The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies
24. Impaired allostimulatory capacity of peripheral blood dendritic cells recovered from hepatitis C virus-infected individuals
25. Pathogenesis of chronic hepatitis C: Immunological features of hepatic injury and viral persistence
26. Protection or damage: A dual role for the virus-specific cytotoxic T lymphocyte response in hepatitis B and C infection?
27. Lymphocyte and macrophage phenotypes in chronic hepatitis C infection. Correlation with disease activity
28. Increases in intrahepatic CD68 positive cells, MAC387 positive cells, and proinflammatory cytokines (particularly interleukin 18) in chronic hepatitis C infection
29. Interleukin-12 induction of Th1 cytokines is important for viral clearance in chronic hepatitis B
30. Diagnostic testing for hepatitis C
31. Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization
32. Chronic inflammation caused by lymphotoxin is lymphoid neogenesis
33. Vigorous peripheral blood cytotoxic T cell response during the acute phase of hepatitis C virus infection
34. Identification of HLA-A3 and -B7-restricted CTL response to hepatitis C virus in patients with acute and chronic hepatitis C
35. Detection of type 2-like T-helper cells in hepatitis C virus infection: Implications for hepatitis C virus chronicity
36. CD30 induction and cytokine profiles in hepatitis C virus core-specific peripheral blood T lymphocytes
37. Progressive liver injury in chronic hepatitis C infection correlates with increased intrahepatic expression of Th1-associated cytokines
38. Semiquantitative analysis of intrahepatic cytokines mRNA in chronic hepatitis C
39. Hepatitis C virus-specific T-cell reactivity during interferon and ribavirin treatment in chronic hepatitis C
40. Host genetic factors influence disease progression in chronic hepatitis C
41. Mutations in immunodominant T cell epitopes derived from the nonstructural 3 protein of hepatitis C virus have the potential for generating escape variants that may have important consequences for T cell recognition
42. Hepatitis C virus (HCV) specific immune responses in anti-HCV positive patients without hepatitis C viraemia
43. Recurrence of hepatitis C virus after loss of virus-specific CD4(+) T-cell response in acute hepatitis C
44. Liver-derived hepatitis C virus (HCV)-specific CD4(+) T cells recognize multiple HCV epitopes and produce interferon gamma
45. Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C
46. + T cells in hepatitis C virus-exposed healthy seronegative donors
47. Analysis of a successful immune response against hepatitis C virus
48. Analysis of successful immune responses in persons infected with hepatitis C virus
49. Different cytokine profiles of peripheral blood mononuclear cells from patients with persistent and self-limited hepatitis C virus infection
50. Immunoregulatory cytokines in chronic hepatitis C virus infection: Pre- and posttreatment with interferon alfa
51. Hepatitis C virus-specific cytolytic T lymphocyte and T helper cell responses in seronegative persons
52. The role of immune responses in the pathogenesis of hepatitis C virus infection
53. Quantitative analysis of hepatitis C virus-specific CD8(+) T cells in peripheral blood and liver using peptide-MHC tetramers
54. + T lymphocyte responses are induced during acute hepatitis C virus infection but are not sustained
55. Mouse CD1-specific NK1 T cells: Development, specificity, and function
56. + natural T cells with distinct cytotoxic activities and Th1, Th2, and Th0 cytokine secretion patterns
57. Natural T cells in the human liver: Cytctoxic lymphocytes with dual T cell and natural killer cell phenotype and function are phenotypically heterogenous and include Valpha24-JalphaQ and gammadelta T cell receptor bearing cells
58. Dynamics of intra-hepatic lymphocytes in chronic hepatitis C: Enrichment for Valpha24+ T cells and rapid elimination of effector cells by apoptosis
59. Life, activation and death of intrahepatic lymphocytes in chronic hepatitis C
60. Cytokine profile of liver- and blood-derived nonspecific T cells after liver transplantation: T helper cells type 1/0 lymphokines dominate in recurrent hepatitis C virus infection and rejection
61. Suppression of host immune response by the core protein of hepatitis C virus: Possible implications for hepatitis C virus persistence
62. The protein kinase-interacting domain in the hepatitis C virus envelope glycoprctein-2 gene is highly conserved in genotype 1-infected patients treated with interferon
63. Expression of hepatitis C virus proteins interferes with the antiviral action of interferon independently of PKR-mediated control of protein synthesis
64. Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein
65. Expression of hepatitis C virus proteins inhibits signal transduction through the Jak-STAT pathway
66. Complex formation between hepatitis C virus core protein and p21Waf1/Cip1/Sdi1
67. NS5A, a nonstructural protein of hepatitis C virus, binds growth factor receptor-bound protein 2 adaptor protein in a Src homology 3 domain/ligand-dependent manner and perturbs mitogenic signaling
68. Activation of nuclear factor kappaB in hepatitis C virus infection: Implications for pathogenesis and hepatocarcinogenesis
69. Hepatitis C virus core protein enhances NF-kappaB signal pathway triggering by lymphotoxin-beta receptor ligand and tumor necrosis factor alpha
70. Hepatitis C virus NS5A protein protects against TNF-alpha mediated apoptotic cell death
71. Progressive development of a Th1-type hepatic cytokine profile in rats with experimental cholangitis
72. Hepatic stellate cell activation and liver fibrosis are associated with necroinflammatory injury and Th1-like response in chronic hepatitis C
73. Hepatic fibrogenesis and hepatitis C
74. Interleukin-10 expression and function in experimental murine liver inflammation and fibrosis
75. Repeated exposure induces periportal fibrosis in Schistosoma mansoni-infected baboons: Role of TGF-beta and IL-4
76. IL-10 and the dangers of immune polarization: Excessive type 1 and type 2 cytokine responses induce distinct forms of lethal immunopathology in murine schistosomiasis
77. Interleukin 10 treatment reduces fibrosis in patients with chronic hepatitis C: A pilot trial of interferon nonresponders
78. Distribution of activated T cells migrating through the body: A matter of life and death
79. Selective retention of activated CD8+ T cells by the normal liver
80. Persistent induction of the chemokine receptor CXCR4 by TGF-beta 1 on synodal T cells contributes to their accumulation within the rheumatoid synovium
81. The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions
82. Chemokine and chemokine receptor interactions provide a mechanism for selective T cell recruitment to specific liver compartments within hepatitis C-infected liver
83. Expression of IFN-inducible protein-10 in chronic hepatitis
84. Differential expression and regulation of chemokines JE, KC, and IP-10 gene in primary cultured murine hepatocytes
85. TNF-alpha is a potent inducer for IFN-inducible protein-10 in hepatocytes and unaffected by GM-CSF in vivo, in contrast to IL-1beta and IFN-gamma
86. Liver-infiltrating T lymphocytes are attracted selectively by IFN-inducible protein-10
87. Active participation of CCR5(+)CD8(+) T lymphocytes in the pathogenesis of liver injury in graft-versus-host disease
88. A chemokine-to-cytokine-to-chemokine cascade critical in antiviral defense
89. Ligands of peroxisome proliferator-activated receptor gamma modulate profibrogenic and proinflammatory actions in hepatic stellate cells
90. Promotion of leukocyte transendothelial cell migration by chemokines derived from human biliary epithelial cells in vitro
91. Increased expression of monocyte chemotactic protein-1 during active hepatic fibrogenesis: Correlation with monocyte infiltration
92. Hepatic stellate cells and the regulation of liver inflammation
93. Monocyte chemotactic protein-1 as a chemoattractant for human hepatic stellate cells
94. Cloning, characterization and genomic organization of LCC-1 (scya16), a novel human CC chemokine expressed in liver
95. The ratio of ELR+ to ELR - CXC chemokines affects the lung and liver injury following hepatic ischemia/reperfusion in the rat